Mayor Charts UNESCO's Course

Spanish biochemist and administrator Federico Mayor Zaragoza, who on November 15 began a six-year term as director-general of the United Nations Educational, Scientific and Cultural Organization, picks up the reins at a critical time for the institution. One challenge is to reverse Western nations’ sense of alienation from UNESCO, and to induce the United States, the United Kingdom and Singapore, which withdrew from the organization in 1984-85, to return to the fold, adding their funding

Written byJacques Richardson
| 8 min read

Register for free to listen to this article
Listen with Speechify
0:00
8:00
Share

Spanish biochemist and administrator Federico Mayor Zaragoza, who on November 15 began a six-year term as director-general of the United Nations Educational, Scientific and Cultural Organization, picks up the reins at a critical time for the institution. One challenge is to reverse Western nations’ sense of alienation from UNESCO, and to induce the United States, the United Kingdom and Singapore, which withdrew from the organization in 1984-85, to return to the fold, adding their funding and talents to those of the 158 current member states. Another is to address spending and management problems that accumulated during the 13-year tenure of Mayor’s predecessor, Amadou Mahtar M’Bow of Senegal. To these and other tasks, Mayor brings a reservoir of international support: more than a hundred prominent world citizens, including 11 Nobel laureates in science, actively promoted his nomination. He also brings to his new post impressive credentials of his own in science ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies